2024
|
Invention
|
Compounds with antifungal properties. Fungal infections are treated by administering MBX-7591, MB... |
2023
|
Invention
|
Inhibitors of bacterial type iii secretion system. PseudomonasChlamydiaChlamydia spp. |
|
Invention
|
Broad-spectrum inhibitors of cytomegalovirus. NN-arylpyrimidamine (NAPA) small molecules is discl... |
2022
|
Invention
|
Metabolically stable n-acylaminooxadiazoles useful as antibacterial agents.
The present inventio... |
|
Invention
|
Compounds and methods for treating malaria.
The present invention is related to the development ... |
|
Invention
|
Compounds and methods for treating malaria. PlasmodiaPlasmodia strains known as the causative age... |
|
Invention
|
Compounds and methods for treating malaria. The present invention is related to the development o... |
2020
|
Invention
|
Compositions and methods of treating or preventing ocular infections with filociclovir.
The pres... |
|
Invention
|
Compositions and methods of treating or preventing ocular infections with filociclovir. The prese... |
|
Invention
|
Compositions and methods for treating or preventing ocular infections with filociclovir. The pres... |
|
Invention
|
Combination drug treatment for human cytomegalovirus.
The present invention is related to the di... |
|
Invention
|
Combination drug treatment for human cytomegalovirus. The present invention is related to the dis... |
|
Invention
|
Inhibition of adenovirus with filociclovir.
The present invention is related to the development ... |
|
Invention
|
Inhibition of adenovirus with filociclovir. A lottery ticket dispensing system includes a cabinet... |
|
Invention
|
Inhibition of adenovirus with filociclovir. The present invention is related to the development o... |
2018
|
Invention
|
Metabolically stable n-acylaminooxadiazoles useful as antibacterial agents. The present invention... |
|
Invention
|
Metabolically stable n-acylaminooxadiazoles useful as antibacterial agents. transtrans-translatio... |
|
Invention
|
Multimeric inhibitors of bacterial type iii secretion system. Organic compounds showing the abili... |
2017
|
Invention
|
Broad spectrum inhibitors of filoviruses. CL) with its host receptor Niemann-Pick C1 (NPC1) prote... |
|
Invention
|
Broad-spectrum inhibitors of filoviruses. The present invention is related to the development of ... |
2014
|
Invention
|
Antimicrobial potentiators. Novel compounds are disclosed having the structure of Formula I:
a p... |
|
Invention
|
Antimicrobial potentiators. Novel compounds are disclosed having the structure of Formula I: wher... |
|
Invention
|
Antimicrobial potentiators |
|
Invention
|
Antimicrobial potentiators. Novel compounds are disclosed having the structure of Formula I. The ... |
2012
|
Invention
|
Aminoalkyl phenol ether inhibitors of influenza a virus. The present invention is directed to the... |
|
Invention
|
Antifungal compounds. The invention provides fungicide and/or antifungal organic compounds and co... |
|
Invention
|
Antimicrobial compounds. The invention provides antimicrobial organic compounds and compositions ... |
|
Invention
|
Inhibitors of bacterial type iii secretion system.
Organic compounds showing the ability to inhi... |
|
Invention
|
Inhibitors of bacterial type iii secretion system. Chlamydia spp. having such type III secretion ... |
|
Invention
|
Inhibitors of bacterial type iii secretion system. Organic compounds showing the ability to inhib... |
2011
|
Invention
|
Inhibitors of viral entry into mammalian cells. The present invention is related to the developme... |
|
Invention
|
Inhibitors of bacterial plasminogen activators.
Organic compounds showing the ability to inhibit... |
2010
|
Invention
|
Inhibitors of botulinum neurotoxins. Organic compounds showing the ability to inhibit Botulinum n... |
|
Invention
|
Inhibitors of filovirus entry into host cells. Organic compounds showing the ability to inhibit v... |
2009
|
Invention
|
Bacterial helicase inhibitor compounds and uses thereof. Organic compounds are described that inh... |
|
Invention
|
Inhibitors of bacterial biofilm formation.
Organic compounds are described for use in inhibiting... |